uric acid has been researched along with mk-0524 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elisaf, MS; Florentin, M; Kei, A; Liberopoulos, EN; Mikhailidis, DP | 1 |
| Elisaf, M; Kei, A; Liberopoulos, E; Tellis, C; Tselepis, A | 1 |
1 review(s) available for uric acid and mk-0524
| Article | Year |
|---|---|
Pleiotropic effects of nicotinic acid: beyond high density lipoprotein cholesterol elevation.
Topics: Animals; Cholesterol, HDL; Drug Therapy, Combination; Flushing; Glucose; Homocysteine; Humans; Hypolipidemic Agents; Indoles; Niacin; Receptors, Immunologic; Receptors, Prostaglandin; Uric Acid | 2011 |
1 trial(s) available for uric acid and mk-0524
| Article | Year |
|---|---|
Effect of switch to the highest dose of rosuvastatin versus add-on-statin fenofibrate versus add-on-statin nicotinic acid/laropiprant on oxidative stress markers in patients with mixed dyslipidemia.
Topics: Aged; Apolipoprotein B-100; Atorvastatin; Bilirubin; Biomarkers; Dinoprost; Drug Therapy, Combination; Dyslipidemias; Female; Fenofibrate; Fluorobenzenes; Greece; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Indoles; Lipoproteins, LDL; Male; Middle Aged; Niacin; Oxidative Stress; Prospective Studies; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Simvastatin; Sulfonamides; Time Factors; Treatment Outcome; Uric Acid | 2014 |